Reliagene Technologies Overview

  • Founded
  • 1990
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Reliagene Technologies General Information

Description

Provider of DNA testing services in courts. The company provides polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), mitochondrial DNA sequencing (mtDNA), and Y- chromosome DNA testing (Y-STR).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Primary Office
  • 5525 Mounes Street
  • Suite 101
  • New Orleans, LA 70123
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Reliagene Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reliagene Technologies‘s full profile, request access.

Request a free trial

Reliagene Technologies Patents

Reliagene Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080206755-A1 First primer for both a filled site containing an interspersed element and an empty site which does not contain the interspersed element, a second primer for the filled site, and a third primer for the empty site; to test any type of interspersed genetic element containing direct repeat sequences Granted 23-Feb-2007 0000000000
US-7794983-B2 First primer for both a filled site containing an interspersed element and an empty site which does not contain the interspersed element, a second primer for the filled site, and a third primer for the empty site; to test any type of interspersed genetic element containing direct repeat sequences Active 23-Feb-2007 0000000000
US-20070003944-A1 Inference of human geographic origins using alu insertion polymorphisms Abandoned 14-Dec-2004 0000000000
US-20060141512-A1 Novel method for separation of human sperm from biological samples for application in human identification Abandoned 03-Dec-2004 0000000000 0
US-20060099620-A1 Polymerase chain reaction for amplifying dna containing a human/chimp mismatch using primers of given sequence Granted 08-Oct-2004 C12Q1/6879 0

Reliagene Technologies Executive Team (4)

Name Title Board Seat Contact Info
Leonard Klevan Ph.D Chief Executive Officer
Anne Montgomery Co-Founder
Sudhir Sinha Ph.D Co-Founder
You’re viewing 3 of 4 executive team members. Get the full list »